The Latest Breaking News from CVS

New CVS unit aims to cut your prescription costs by offering alternatives to branded drugs.

Ana Walshe’s body has not been found, but prosecutors are trying to prove that her husband, Brian Walshe, murdered and dismembered the mother-of-three

A market correction is underway as the major indexes and leading stocks broke key support this week amid surging Treasury yields.

The Dow Jones fell despite Walmart earnings and Cisco earnings beating views. Cathie Wood snapped up a beaten down stock. CVS stock cratered.

The stock market is not making much progress. Buffett stock plunges while Cisco leads the S&P 500.

With rising healthcare spending, the drugstore industry is poised to witness solid growth amid heightened demand. As a result, leading industry players CVS Health (CVS), Walgreens Boots Alliance (WBA), and Rite Aid (RAD) stand to benefit. However, should you Buy, Hold, or Sell these stocks? Keep reading to find out.

Blue Shield of California will end its CVS Health prescription benefit management contract and tap Amazon to replace it.

Uninsured can get their COVID-19 shots at community and state health departments, but a partnership with pharmacies is still in the works.

The medical sector is expected to grow amid steady demand and technological advancements. So, let's analyze which of these stocks, CVS Health (CVS), Walgreens Boots Alliance (WBA), and TRxADE HEALTH (MEDS), has the better growth opportunities.

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.61%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.88%. Stock indexes this morning are lower after Fitch Ratings’ downgrade of U.S. government debt spurred a risk-off sentiment in stocks. Stocks are also under pressure...

September S&P 500 futures (ESU23) are trending down -0.54% this morning as risk sentiment took a hit after rating agency Fitch downgraded the United States’ credit rating while market participants awaited new economic data on the labor market.